Correlation Between Stoke Therapeutics and Crispr Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Crispr Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Crispr Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Crispr Therapeutics AG, you can compare the effects of market volatilities on Stoke Therapeutics and Crispr Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Crispr Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Crispr Therapeutics.
Diversification Opportunities for Stoke Therapeutics and Crispr Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Stoke and Crispr is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Crispr Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crispr Therapeutics and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Crispr Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crispr Therapeutics has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Crispr Therapeutics go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Crispr Therapeutics
Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Crispr Therapeutics. In addition to that, Stoke Therapeutics is 1.11 times more volatile than Crispr Therapeutics AG. It trades about -0.06 of its total potential returns per unit of risk. Crispr Therapeutics AG is currently generating about 0.03 per unit of volatility. If you would invest 5,076 in Crispr Therapeutics AG on September 2, 2024 and sell it today you would earn a total of 41.00 from holding Crispr Therapeutics AG or generate 0.81% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Stoke Therapeutics vs. Crispr Therapeutics AG
Performance |
| Timeline |
| Stoke Therapeutics |
| Crispr Therapeutics |
Stoke Therapeutics and Crispr Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Crispr Therapeutics
The main advantage of trading using opposite Stoke Therapeutics and Crispr Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Crispr Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crispr Therapeutics will offset losses from the drop in Crispr Therapeutics' long position.| Stoke Therapeutics vs. Tff Pharmaceuticals | Stoke Therapeutics vs. Eliem Therapeutics | Stoke Therapeutics vs. Inhibrx | Stoke Therapeutics vs. Enliven Therapeutics |
| Crispr Therapeutics vs. Beam Therapeutics | Crispr Therapeutics vs. Editas Medicine | Crispr Therapeutics vs. Caribou Biosciences | Crispr Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |